课题基金 / 基金详情

RECOMBINANT HUMAN MAST CELL TRYPTASES

RECOMBINANT HUMAN MAST CELL TRYPTASES
重组人肥大细胞类胰蛋白酶
批准号:
6159344
负责人:
David Andrew Johnson
金额:
$12.7万
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-08-01 至 2004-07-31

项目摘要

项目成果

David Andrew Johnson的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (from applicant's abstract): Human mast cell tryptases (trypsin-like serine proteases) are the major protein products of mast cells suggesting that they play an important role in the function of mast cells. Based on published cDNA sequences there are four different human tryptases and the principal investigator hypothesizes that these different mast cell tryptases have different functional characteristics that allow for different functions. The presence of mast cells in almost all tissues indicate that tryptases have significant functions in native an pathological conditions and the general lack of knowledge concerning how these enzymes differ in function provide the rationale for the proposal. The central hypothesis is that the different mast cell tryptases have evolved to serve different functions and that knowledge of the structures and functions of these enzymes is critical to understanding the roles of mast cells in health and disease. In preliminary studies the principal investigator has expressed and purified fully active recombinant human skin tryptase 1 (rHST1) in Pichia pastoris. In Aim 1 site-directed mutagenesis of rHST1 cDNA will be used to express human tryptase beta/2 and tryptase alpha in Pichia pastoris. In Aim 2 Tryptases 1, beta/2 and alpha will be characterized and compared with regard to heparin binding and kinetics on synthetic and natural substrates to define their differences and similarities. In Aim 3 based on the finding that human lung tryptase rapidly and specifically cleaves the single RGD motif in fibrinogen that is bound by alphav-beta-3 integrins, other proteins with RGD sites, including vitronectin and fibronectin, will be examined for cleavage by the three rHTs. This work will provide needed comparative data on tryptases of known sequence and should yield insight as to why humans have such similar, yet different, enzymes in mast cells. Support will allow this laboratory to continue the study of tryptases and the mentoring of undergraduate students, while gaining knowledge that could improve our understanding of the roles of mast cells in diseases, such as asthma, arthritis, cancer, and cardiovascular diseases.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Human mast cell proteases: activity assays using thiobenzyl ester substrates.
人肥大细胞蛋白酶:使用硫代苄酯底物进行活性测定。
DOI: 10.1385/1-59259-967-2:193
发表时间: 2006
期刊: Methods in molecular biology (Clifton, N.J.)
影响因子: --
作者: [Johnson,DavidA]
通讯作者: Johnson,DavidA
Recombinant human mast-cell chymase: an improved procedure for expression in Pichia pastoris and purification of the highly active enzyme.
重组人肥大细胞糜酶:一种在毕赤酵母中表达和纯化高活性酶的改进程序。
DOI: 10.1042/ba20040074
发表时间: 2005
期刊: Biotechnology and applied biochemistry
影响因子: 2.8
作者: [Lockhart,BrentE, Vencill,JessicaR, Felix,CheriseM, Johnson,DavidA]
通讯作者: Johnson,DavidA
Human Cathepsin G: Expression, C-Terminal Processing and Dual Specificity
  • 批准号:
    7195586
  • 项目类别:
  • 资助金额:
    $21.02万
  • 财政年份:
    2007
  • 负责人:
    David Andrew Johnson
  • 依托单位:
CYCLODIENE INDUCED BINDING PROTEIN
  • 批准号:
    2019237
  • 项目类别:
  • 资助金额:
    $9.68万
  • 财政年份:
    1997
  • 负责人:
    David Andrew Johnson
  • 依托单位:
EFFECTS OF O3 AND NO2 ON HUMAN LUNG PROTEINS
  • 批准号:
    3253210
  • 项目类别:
  • 资助金额:
    $13.53万
  • 财政年份:
    1990
  • 负责人:
    David Andrew Johnson
  • 依托单位:
EFFECTS OF O3 AND NO2 ON HUMAN LUNG PROTEINS
  • 批准号:
    3253212
  • 项目类别:
  • 资助金额:
    $12.91万
  • 财政年份:
    1990
  • 负责人:
    David Andrew Johnson
  • 依托单位:
海外基金